Richter-Helm's Biomanufacturing Facility Expansion Progress: Inauguration of New Office Building

May 31, 2023 PR-M06-23-03

BOVENAU, Germany – Richter-Helm BioLogics has reached a further and important construction milestone during the expansion of its production site in Bovenau. We officially and ceremoniously inaugurated the new office building on May 31, 2023 together with the mayor of Bovenau, Mr. Ambrock, two years after the groundbreaking ceremony.

“The new office building offers our employees a modern open-space workplace including an in-house canteen. Next week our employees will be able to move in and start their work,” said Dr. Pohlmeyer, Managing Director at Richter-Helm.

RichterHelm_PressRelease_Img1_061223

Source: Richter-Helm BioLogics, 2023

With an investment of €95 million, Richter-Helm is going to triple the current production capacity with the installment of two additional highly flexible and fully equipped production trains with interchangeable product flows offering further capacities for late stage and commercial products. Bioreactor capacities of 300 liters and 1,500 liters will be added.

By the middle of next year, we will be able to start GMP-compliant production at the new site, offering space for new clients and their pDNA and protein-based projects.

RichterHelm_PressRelease_Img2_061223

Source: Richter-Helm BioLogics, 2023

 

About Richter-Helm BioLogics

Richter-Helm is a leading Germany-based contract development and cGMP manufacturing organization with its headquarters based in Hamburg, Germany. Over the past 30 years Richter-Helm gained substantial experience in the development and manufacture of different product classes e.g. recombinant proteins, antibodies, vaccines and plasmid DNA (pDNA, using its proprietary pDNA process RHB-pART). The company currently operates a development facility and two cGMP manufacturing facilities for microbial production. Richter-Helm offers highly specialized contract development and manufacturing services to support the global pharmaceutical and biotechnological industries with end-to-end services including strain development, process development and supply of products for clinical trials and commercial material.

 

Contact

Dr. Kai Pohlmeyer
Managing Director
Phone: +49 40 55290-430
k.pohlmeyer@richter-helm-biologics.eu
BusinessDevelopment@richter-helm-biologics.eu
https://www.richter-helm.eu/

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Richter-Helm BioLogics

Richter-Helm is a leading Germany-based contract development and cGMP manufacturing organization with its headquarters based in Hamburg, Germany. Over the past 30 years Richter-Helm gained substantial experience in the development and manufacture of different product classes e.g. recombinant proteins, antibodies, vaccines and plasmid DNA (pDNA, using its proprietary pDNA process RHB-pART). The company currently operates a development facility and two cGMP manufacturing facilities for microbial production. Richter-Helm offers highly specialized contract development and manufacturing services to support the global pharmaceutical and biotechnological industries with end-to-end services including strain development, process development and supply of products for clinical trials and commercial material.

Q: